Preferred Label : carcinoembryonic antigen;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.has-sante.fr/jcms/p_3498143/fr/penumbra-ace
2024
France
health technology assessment
carcinoembryonic antigen
Catheter
Cyclophosphamide/Doxorubicin
Cisplatin/Cytarabine/Etoposide
pulmonary aspiration, nos
Angiotensin Converting Enzyme Measurement
Catheter Device
carcinoembryonic antigen
catheter, nos
Aspiration, CTCAE
catheterization
Aspiration
Angiotensin-Converting Enzyme
ACE Gene
suction
Respiratory Tract Aspiration

---
https://www.has-sante.fr/jcms/p_3309882/fr/penumbra-system-incluant-le-catheter-de-reperfusion-penumbra-ace-68-penumbra-system-incluant-le-catheter-de-reperfusion-penumbra-ace-60
2022
France
health technology assessment
suction
catheter, nos
reperfusion
carcinoembryonic antigen
carcinoembryonic antigen
catheterization
pulmonary aspiration, nos

---
https://www.has-sante.fr/jcms/p_3289068/fr/penumbra-ace-68-penumbra-ace-60
2021
France
health technology assessment
artery, nos
cerebral arteries
carcinoembryonic antigen
catheterization
brain, nos
reperfusion
Artery
catheter, nos
carcinoembryonic antigen

---
https://www.has-sante.fr/jcms/p_3145945/fr/penumbra-system-incluant-le-catheter-d-acces-distal-penumbra-ace-68-penumbra-system-incluant-le-catheter-de-reperfusion-penumbra-ace-60
2020
France
health technology assessment
carcinoembryonic antigen
vascular access devices
Apert syndrome
Acromegaly
pulmonary aspiration, nos
suction
reperfusion
catheter, nos

---
https://www.has-sante.fr/jcms/p_3198900/fr/penumbra-system-incluant-le-catheter-de-reperfusion-penumbra-ace-68-penumbra-system-incluant-le-catheter-de-reperfusion-penumbra-ace-60
2020
France
health technology assessment
suction
Acromegaly
catheterization
pulmonary aspiration, nos
Apert syndrome
reperfusion
catheter, nos
carcinoembryonic antigen

---
Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.